Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • x ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • x Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (9)
Poster categories
  • e-Thematic Poster Session (11)
  • Thematic Poster Session (90)
keywords
Session Reference
  • L-TPS06 (8)
  • L-TPS07 (2)
  • L-TPS08 (1)
  • L-TPS10 (1)
  • L-TPS11 (3)
  • L-TPS18 (2)
  • L-TPS20 (3)
  • L-TPS21 (5)
  • TPS02 (1)
  • TPS05 (1)
  • TPS09 (2)
  • TPS11 (1)
  • TPS15 (3)
  • TPS16 (14)
  • TPS17 (2)
  • TPS28 (1)
  • TPS31 (1)
  • TPS39 (1)
  • TPS40 (12)
  • TPS41 (5)
  • TPS43 (2)
  • TPS49 (1)
  • TPS54 (1)
  • TPS55 (5)
  • TPS56 (2)
  • TPS57 (3)
  • TPS65 (8)
  • TPS67 (4)
  • TPS68 (2)
  • TPS69 (1)
109 results
Thumbnail

D2.343 - Use of IDDA 2.1 score in Common Variable Immunodeficiency (CVID): a single center experience

Thumbnail

D2.344 - Unraveling the Mysteries of Chronic Granulomatous Disease: A Case of detected Protein Deficiency Amidst Negative Genetic Screening

Thumbnail

D2.349 - Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities

Thumbnail

D2.350 - CVID: the crossroad between immune dysregulation, autoimmunity and cancer

Thumbnail

D2.54 - Basophil Activation Test for Chronic Spontaneous Urticaria: the experience of a paediatric allergy centre

Thumbnail

D2.57 - Recurrent pleural effusion in patient with hereditary angioedema: a case report

Thumbnail

- D3.124 - Severe asthma associated with hereditary angioedema type 1 and other pathologies

Thumbnail

- D3.130 - Selective IgA Deficiency in the Pediatric Population: A Gateway to Allergies and Autoimmunity

Thumbnail

D3.317 - Moderate-to-severe infections and initial SELENA-SLEDAI correlate with the incidence of flares in patients with Systemic Lupus Erythematosus

Thumbnail

D3.322 - Acquired chronic granulomatous disease secondary to myelodysplastic disorder

Thumbnail

D3.324 - Mastoiditis as complication of Hyper IgM syndrome

Thumbnail

D3.326 - A RARE COEXISTENCE: CARD9 DEFICIENCY AND IgG4-RELATED DISEASE IN A PEDIATRIC PATIENT

Thumbnail

D3.327 - Use of C1 Inhibitor Subcutaneously in the United Kingdom

Thumbnail

D3.328 - Relapsing COVID-19 pneumonia and Helicobacter cineadi cellulitis in a patient with X-linked agammaglobulinemia

Thumbnail

D3.332 - Determination of Reference Intervals for IgG, IgA, and IgM Levels by Age in Healthy Adults

Thumbnail

D3.348 - A Case of 19p13.3 Microdeletion

Thumbnail

D3.349 - Evaluation of natural killer cells in female infertility

Thumbnail

D3.138 - Asthma remission in EGPA patients: applicability and concordance of the main international guidelines

Thumbnail

D3.193 - Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study

Thumbnail

D3.306 - Successful treatment of severe atopic dermatitis in teenage patient with hyper-IgE syndrome (STAT3 mutation)

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM